Cellectar Biosciences (CLRB) PT Lowered to $12 at Oppenheimer
Tweet Send to a Friend
(Updated - November 19, 2024 8:17 AM EST)
Oppenheimer analyst Jeff Jones lowered the price target on Cellectar Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jeff Jones lowered the price target on Cellectar Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
